Content equals the label
Purity (%) and content (the actual amount delivered) are not the same thing. We document both, so the amount on the label is the amount you receive — no quiet shortfalls.
B2B Documentation Support
Use this page to align sourcing files, quotation scope, packaging, and buyer-side review before comparing supplier options.
Co-formulated vial containing CJC-1295 without DAC 5mg and Ipamorelin 5mg, for qualified B2B sourcing, with per-component batch documentation and custom fill discussion.
Key Review Snapshot
Why buyers trust WUMO
In this market, “99% pure” is often quoted while the amount actually delivered is far less. We keep purity and real content separate, and put both on paper — so CJC-1295 without DAC 5mg + Ipamorelin 5mg Co-Formulated Vial is backed by documents you can check.
Research peptide line — typical purity >99.3–99.4%, every batch MS-checked before release.
Purity (%) and content (the actual amount delivered) are not the same thing. We document both, so the amount on the label is the amount you receive — no quiet shortfalls.
Identity and quality are confirmed by batch documentation — COA, plus HPLC / MS where applicable — before material is released.
Ingredient identity (INCI / CAS), specification sheet and SDS are available for review. Match the documents to your quoted batch before you commit.
Documents Available
COA
Batch-level quality summary for buyer-side file review.
Request this file through the inquiry path below.
HPLC
Purity profile reference for the quoted project or batch where available.
Request this file through the inquiry path below.
MS
Identity confirmation support for documentation review where available.
Request this file through the inquiry path below.
SDS
Safety document requested for internal purchasing and handling review.
Request this file through the inquiry path below.
Spec
Product or packaging specification reference for quotation alignment.
Request this file through the inquiry path below.
Overview
B2B Review Guide
This is a co-formulated lyophilized vial containing two peptides: Modified GRF (1-29) — commercially listed as CJC-1295 without DAC — at 5mg, and Ipamorelin at 5mg. It is supplied for qualified B2B research sourcing projects. This page describes sourcing and analytical documentation only; it does not describe biological action, combination rationale, end-user application, or product performance.
A batch-specific COA is issued for the batch being supplied and states the RP-HPLC and mass-spectrometry results for that batch. Purity and peptide content are separate specifications — see what a 10mg vial actually contains for the distinction and what a per-vial claim needs behind it.
Karl Fischer water content, counter-ion form, and appearance are not part of the standard vial COA scope and are arranged per project where a buyer specification requires them. Ask for the COA of the batch being quoted, and check that the batch identifier on it matches the vial label.
This page is for qualified B2B technical evaluation and business-side documentation review only. Material is supplied for research and laboratory use. It is not intended for individual purchase, consumer use, or product-use guidance, and WUMO does not provide medical guidance or outcome claims. Final use, importation, labeling, and local compliance are the buyer's responsibility.
One COA is fine, but it should distinguish the components and say how identity and purity were assessed for each. A single combined purity figure does not adequately describe the purity of either component.
Only where the analytical method separates the two peptides well enough to support it. Ask what method was used before treating two percentages as equivalent to two single-component COAs.
Yes, alternative ratios and fill quantities are set per project. Whatever is agreed should appear in the written specification and on the vial label.
Company and business type, destination market, intended business use, required documentation package, target ratio and fill quantity, vial count, packaging preference, and required timeline.
OEM / Private Label
For finished lyophilized peptide vials with custom labels and packaging -- covering MOQ, sample or pilot evaluation, and batch documentation such as COA, sterility, and endotoxin reports -- see our private label peptide vial (OEM / ODM) service.
Use this form for pricing, technical files, sample requests, or project discussion for this product.
Need COA, SDS/MSDS, or specifications? Choose "Technical document request" in the inquiry form or mention the file name in your message.